Unlimited access to the most powerful analytical tools in finance.

Subscribe for $2
Overview
Profile
Zenabis Global Stock

Zenabis Global Stock ZENA.TO

ZENA.TO
CA98936N1024
A2PBNN

Price

0.15
Today +/-
+0
Today %
+0 %

Zenabis Global stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Zenabis Global stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Zenabis Global stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Zenabis Global stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Zenabis Global's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Zenabis Global Stock Price History

DateZenabis Global Price
6/1/20210.15 undefined
5/31/20210.15 undefined

Zenabis Global Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Zenabis Global, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Zenabis Global from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Zenabis Global’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Zenabis Global. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Zenabis Global’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Zenabis Global’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Zenabis Global’s growth potential.

Zenabis Global Revenue, EBIT and net profit per share

DateZenabis Global RevenueZenabis Global EBITZenabis Global Net Income
202059.3 M undefined835,900 undefined-70.46 M undefined
201930.44 M undefined-33.6 M undefined-127.05 M undefined
201832.79 M undefined4.84 M undefined2.7 M undefined
201733.35 M undefined4.46 M undefined3.06 M undefined
201631.17 M undefined4 M undefined2.83 M undefined
201526.22 M undefined2.3 M undefined1.2 M undefined
201423.31 M undefined1.76 M undefined738,750 undefined
201320.59 M undefined1.03 M undefined180,000 undefined
201218.9 M undefined1.06 M undefined570,000 undefined
201118.26 M undefined740,000 undefined40,000 undefined
201019.92 M undefined1.86 M undefined1.06 M undefined
200917.88 M undefined1.27 M undefined770,000 undefined
200819.76 M undefined890,000 undefined-640,000 undefined
200719.8 M undefined1.63 M undefined-280,000 undefined
200622.04 M undefined2.52 M undefined800,000 undefined
200521.76 M undefined2.32 M undefined990,000 undefined
200419.5 M undefined2.29 M undefined560,000 undefined
200320.07 M undefined3.7 M undefined1.91 M undefined
200213.58 M undefined1.43 M undefined310,000 undefined
200112.02 M undefined1.08 M undefined130,000 undefined

Zenabis Global Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
20012002200320042005200620072008200920102011201220132014201520162017201820192020
1213201921221919171918182023263133323059
-8.3353.85-5.0010.534.76-13.64--10.5311.76-5.26-11.1115.0013.0419.236.45-3.03-6.2596.67
25.0030.7735.0031.5828.5731.8231.5826.3229.4126.3222.2222.2225.0021.7423.0825.8130.3028.13120.0055.93
34766765554455681093633
001000000100001232-127-70
---------------100.0050.00-33.33-6,450.00-44.88
22.222.222.223.1425.225.5425.5425.5425.5425.5425.5425.5425.5425.5427.0425.5625.9526.22239.45549.93
--------------------
Details

Keystats

ⓘ

Revenue and Growth

The Zenabis Global Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Zenabis Global is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (k)
LONG-T. REC. (k)
INTANGIBLE ASSETS (k)
GOODWILL (k)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (k)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (k)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (k)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
20012002200320042005200620072008200920102011201220132014201520162017201820192020
                                       
0.350.280.20.480.360.060.030.570.512.340.650.630.331.071.22.044.815.1816.575.73
0.722.272.532.354.323.222.683.431.561.953.222.081.541.22.622.813.1311.668.34
0000.450.470.270.180.180.180.20.090.020000001.763.13
0.851.091.371.511.991.512.832.22.291.61.680.891.271.51.711.71.982.5453.8272.5
0.050.10.270.180.040.110.050.10.050.090.080.780.671.11.060.871.11.076.216.85
1.973.744.374.977.185.175.776.484.596.185.74.324.355.215.177.2310.6911.9190.0196.55
17.592122.2632.4131.3430.1128.9827.8626.7926.5227.7732.731.5832.6835.5538.3942.8147.73211.08133.43
00000000000000000139.70160.32
00000690660000000000000265.1
000000021011000000000000
300260260260260260640260260260520520520522.67522.67522.67522.67522.6700
0.070.020.010.070.040.040.61.540.530.170.170.1900000007.38
17.9621.2822.5332.7431.6431.130.8829.8727.6926.9528.4633.4132.133.236.0738.9143.3348.39211.08141.24
19.9325.0226.937.7138.8236.2736.6536.3532.2833.1334.1637.7336.4538.4141.2546.1454.0360.31301.1237.79
                                       
2.672.672.673.163.894.014.014.014.014.014.014.014.014.014.014.014.114.18225.22273.9
000001040707070100100100104.37154.01231.52245.93240.5200
1.331.643.554.115.15.95.624.985.756.86.8410.1210.311.0412.2415.0618.1320.83-162.2-213.86
000000000000000000-0.2519.45
00000000000000.740.740.740.744.900
44.316.227.278.999.929.679.069.8310.8810.9514.2314.4115.917.1420.0523.2230.1462.7779.49
00000001.570.520.911.260.8100000000
0000000026049032053000000000
000.5200000.040.060.070.040.08000000.9439.8634.09
1.431.670.990.541.3910.040000000000000
0.731.191.592.332.4721.936.222.271.181.161.011.231.211.412.753.112.292.380.0166.89
2.162.863.12.873.8622.936.263.882.022.632.632.651.211.412.753.112.293.24119.86100.98
11.0913.9214.1123.7521.590.0216.2422.219.7218.719.8119.6818.4717.2117.4618.0522.119.9859.8825.38
1.051.071.281.621.451.582.031.220.720.940.751.171.151.581.892.293.384.637.10.09
13049044040025025000000000000000
12.2715.4815.8325.7723.291.8518.2723.4220.4419.6420.5620.8519.6218.7919.3520.3425.4824.666.9825.47
14.4318.3418.9328.6427.1524.7824.5327.322.4622.2723.1923.520.8320.222.123.4527.7727.84186.85126.45
18.4322.6525.1535.9136.1434.734.236.3632.2933.1534.1437.7335.2436.0939.2443.550.9957.98249.62205.93
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Zenabis Global provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Zenabis Global's financial health and stability.

Assets

Zenabis Global's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Zenabis Global must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Zenabis Global after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Zenabis Global's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (k)
CHANGES IN WORKING CAPITAL (k)
NON-CASH ITEM (M)
PAID INTEREST (k)
PAID TAXES (k)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (k)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
20012002200320042005200620072008200920102011201220132014201520162017201820192020
001000000100001222-72-54
01112111111111112242
00000000000000001,0000-1,0000
0000-1,00000-1,0001,0000-1,0001,000000000-18,000-9,000
000000000000000000944
001,0001,0001,0001,0001,0001,0001,00000000000000
0001,0000000000000000000
102213203402133454-78-17
-5-4-2-10-10000-1-2-30-1-4-4-6-2-86-1
-5,000-4,000-2,000-10,0000-1,000-1,00000-1,000-2,000-2,0000-1,000-4,000-4,000-6,000-2,000-92,0001,000
000000000000000000-52
00000000000000000000
4308-1-202-3-100-1-1103-257-22
0000000000000000005632
4308-1-2-10-2-100-1-1104-11705
0000000-1100000000056-4
00000000000000000000
0000000001-100000200-10
00000000000000000000
00000000000000000000

Zenabis Global stock margins

The Zenabis Global margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Zenabis Global. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Zenabis Global.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Zenabis Global's sales revenue. A higher gross margin percentage indicates that the Zenabis Global retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Zenabis Global's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Zenabis Global's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Zenabis Global's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Zenabis Global. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Zenabis Global's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Zenabis Global Margin History

Zenabis Global Gross marginZenabis Global Profit marginZenabis Global EBIT marginZenabis Global Profit margin
202057.1 %1.41 %-118.81 %
2019119.98 %-110.38 %-417.41 %
201830.27 %14.76 %8.23 %
201730.81 %13.38 %9.16 %
201627.63 %12.82 %9.07 %
201525.94 %8.76 %4.57 %
201425.39 %7.57 %3.17 %
201324.67 %5 %0.87 %
201225.19 %5.61 %3.02 %
201124.86 %4.05 %0.22 %
201029.02 %9.34 %5.32 %
200929.53 %7.1 %4.31 %
200827.58 %4.5 %-3.24 %
200733.18 %8.23 %-1.41 %
200631.9 %11.43 %3.63 %
200531.11 %10.66 %4.55 %
200431.85 %11.74 %2.87 %
200335.97 %18.44 %9.52 %
200230.56 %10.53 %2.28 %
200126.54 %8.99 %1.08 %

Zenabis Global Stock Sales Revenue, EBIT, Earnings per Share

The Zenabis Global earnings per share therefore indicates how much revenue Zenabis Global has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Zenabis Global earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Zenabis Global's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Zenabis Global’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zenabis Global's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Zenabis Global Revenue, EBIT and net profit per share

DateZenabis Global Sales per ShareZenabis Global EBIT per shareZenabis Global Earnings per Share
20200.11 undefined0 undefined-0.13 undefined
20190.13 undefined-0.14 undefined-0.53 undefined
20181.25 undefined0.18 undefined0.1 undefined
20171.28 undefined0.17 undefined0.12 undefined
20161.22 undefined0.16 undefined0.11 undefined
20150.97 undefined0.08 undefined0.04 undefined
20140.91 undefined0.07 undefined0.03 undefined
20130.81 undefined0.04 undefined0.01 undefined
20120.74 undefined0.04 undefined0.02 undefined
20110.71 undefined0.03 undefined0 undefined
20100.78 undefined0.07 undefined0.04 undefined
20090.7 undefined0.05 undefined0.03 undefined
20080.77 undefined0.03 undefined-0.03 undefined
20070.78 undefined0.06 undefined-0.01 undefined
20060.86 undefined0.1 undefined0.03 undefined
20050.86 undefined0.09 undefined0.04 undefined
20040.84 undefined0.1 undefined0.02 undefined
20030.9 undefined0.17 undefined0.09 undefined
20020.61 undefined0.06 undefined0.01 undefined
20010.54 undefined0.05 undefined0.01 undefined

Zenabis Global business model

Zenabis Global Inc is a globally operating company specializing in the cultivation and processing of cannabis for medical and therapeutic purposes. The company was founded in 2013 in Vancouver, Canada and has since relocated its headquarters to Halifax, Nova Scotia. Zenabis Global Inc's business model is focused on producing high-quality cannabis for medical use. The company operates various divisions that focus on different steps of the production process, including cultivation and breeding lines, processing and production facilities, as well as distribution and marketing. The company operates seven different production facilities in Canada and Europe, where cannabis is grown, harvested, dried, and processed. All facilities operate according to the highest standards to ensure the quality of their products and satisfy customers. Zenabis Global Inc's product divisions include dried cannabis, cannabis oils, capsules, and sprays, all intended for medical use. They also offer lifestyle products such as tea and chocolate. All products are strictly regulated and undergo extensive controls to ensure they meet the highest quality standards. As one of the largest providers of medical cannabis in Canada, Zenabis Global Inc is also expanding into international markets and exploring new sales opportunities. The company has subsidiaries in Europe, Asia, and Latin America to distribute its products and meet the demand for medical cannabis. The history of Zenabis Global Inc dates back to 2013 when it was founded in Vancouver, Canada under the name International Herbs Medical Marijuana Ltd. Its goal was to produce medical cannabis from cannabis plants and deliver it to qualified patients. Over the years, the company underwent several name changes and restructurings before going public as Zenabis Global Inc in January 2019. The company quickly expanded and acquired several other companies to expand its production capacity and distribution channels. In March 2020, Zenabis Global Inc celebrated the opening of its largest facility, a 2.1 million square meter cultivation and production facility in Langley, British Columbia. This facility has proven to be a vital part of the company, significantly increasing the production of medical cannabis. Zenabis Global Inc offers a variety of products and services for the medical use of cannabis. These include dried cannabis in various strains and strengths, cannabis oils, capsules, sprays, tea, and chocolate. The company also provides a wide range of services for medical cannabis patients, including training programs to educate patients about the different types of cannabis, their application, and their effects. Additionally, Zenabis Global Inc. provides consulting services for physicians and healthcare providers to assist them in prescribing medical cannabis and inform them about the legal aspects of prescribing cannabis medications. Through its efforts to ensure the highest production standards, Zenabis Global Inc has established itself as a leading provider of medical cannabis. The company is committed to expanding its production capacity and sales opportunities worldwide to meet the demand for high-quality medical cannabis and fulfill the needs of patients and physicians. Zenabis Global is one of the most popular companies on Eulerpool.com.

Zenabis Global SWOT Analysis

Strengths

Zenabis Global Inc has established a solid market presence in the cannabis industry. The company's products are well-recognized and trusted by consumers, contributing to its competitive advantage.

Zenabis offers a wide range of cannabis products, including dried flower, oils, and edibles. This diverse product portfolio allows the company to cater to various customer preferences and capture different market segments.

Weaknesses

Zenabis primarily operates within Canada, limiting its potential market reach. Expanding its geographic presence could provide growth opportunities and reduce dependency on a single market.

The company relies on third-party suppliers for certain raw materials, which may affect the quality and consistency of its products. Establishing more self-sustainability in the supply chain would reduce potential risks.

Opportunities

The increasing trend of cannabis legalization provides Zenabis with significant growth opportunities. Expanding operations into new markets and establishing partnerships can help capitalize on this evolving landscape.

As more research backs the medical benefits of cannabis, the demand for cannabis-based treatments is expected to rise. Zenabis can leverage its expertise to develop innovative medical products and tap into this emerging market segment.

Threats

The cannabis industry is becoming increasingly competitive, with numerous players vying for market share. Zenabis needs to continuously differentiate itself through product quality, branding, and differentiation to stay ahead of the competition.

Regulations surrounding cannabis production and distribution can change rapidly, posing challenges for companies like Zenabis. Complying with evolving regulations, licensing requirements, and addressing potential legal hurdles is crucial for sustained success.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Zenabis Global Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Zenabis Global historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Zenabis Global shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Zenabis Global earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Zenabis Global's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Zenabis Global’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zenabis Global's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Zenabis Global stock splits

In Zenabis Global's history, there have been no stock splits.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Zenabis Global.

Most common questions regarding Zenabis Global

What values and corporate philosophy does Zenabis Global represent?

Zenabis Global Inc represents a set of core values and a corporate philosophy that drives its operations. The company is committed to producing high-quality cannabis products while maintaining a focus on responsible and sustainable practices. Zenabis Global Inc values transparency, integrity, and innovation in all aspects of its business. It prioritizes customer satisfaction, prioritizing the needs and preferences of its clientele. With a strong emphasis on research and development, Zenabis Global Inc strives to continuously improve its products and stay at the forefront of the evolving cannabis industry. By integrating environmental stewardship and social responsibility, Zenabis Global Inc aims to create value for its shareholders and contribute to the overall well-being of its stakeholders.

In which countries and regions is Zenabis Global primarily present?

Zenabis Global Inc is primarily present in Canada. The company is a leading Canadian licensed producer of medical and recreational cannabis. With facilities strategically located in British Columbia, New Brunswick, and Nova Scotia, Zenabis has a strong presence in key regions across Canada. As a vertically integrated cannabis company, Zenabis operates cultivation, processing, and distribution facilities to meet the growing demand for its high-quality cannabis products. By focusing on the domestic market, Zenabis aims to drive growth and provide top-notch cannabis experiences to its Canadian customers.

What significant milestones has the company Zenabis Global achieved?

Zenabis Global Inc has achieved several significant milestones. The company successfully listed on the Toronto Stock Exchange and became a publicly traded entity. They also expanded their cultivation capacity to meet the growing demand for cannabis products. In addition, Zenabis Global Inc entered into several strategic partnerships and collaborations to enhance its market presence and distribution channels. The company focused on producing high-quality cannabis products and received various certifications, including Good Manufacturing Practices and Organic Certification. These milestones demonstrate Zenabis Global Inc's commitment to growth, innovation, and market leadership in the cannabis industry.

What is the history and background of the company Zenabis Global?

Zenabis Global Inc is a renowned Canadian-based cannabis company that was founded in 2013. It operates as a licensed producer, distributor, and seller of medical and recreational cannabis products. With a focus on quality and sustainability, Zenabis is dedicated to fulfilling the increasingly popular demand for cannabis globally. The company's state-of-the-art facilities and innovative cultivation techniques enable it to consistently produce premium, high-quality cannabis products. By prioritizing customer satisfaction, Zenabis aims to become a leading player in the global cannabis industry. With its progressive approach and commitment to excellence, Zenabis Global Inc continues to play a pivotal role in the cannabis market.

Who are the main competitors of Zenabis Global in the market?

The main competitors of Zenabis Global Inc in the market include major cannabis producers such as Canopy Growth Corporation, Aurora Cannabis Inc, Tilray Inc, Aphria Inc, and Cronos Group Inc.

In which industries is Zenabis Global primarily active?

Zenabis Global Inc is primarily active in the cannabis industry.

What is the business model of Zenabis Global?

The business model of Zenabis Global Inc focuses on the production and distribution of cannabis products. As a licensed producer, Zenabis operates cultivation facilities where they grow and harvest cannabis plants. They then process the plants to create various cannabinoid products such as dried cannabis flower, cannabis oil, and other derivative products. Zenabis aims to serve both the medical and recreational cannabis markets, providing high-quality, safe, and consistent products to consumers. By leveraging their expertise in cultivation and processing, Zenabis strives to be a leading player in the cannabis industry, meeting the growing demand and delivering value to its shareholders.

What is the P/E ratio of Zenabis Global 2025?

The P/E ratio cannot be calculated for Zenabis Global at the moment.

What is the P/S ratio of Zenabis Global 2025?

The P/S cannot be calculated for Zenabis Global currently.

What is the Quality Investing of Zenabis Global?

The Quality Investing for Zenabis Global is 3/10.

What is the revenue of Zenabis Global 2025?

The revenue cannot currently be calculated for Zenabis Global.

How high is the profit of Zenabis Global 2025?

The profit cannot currently be calculated for Zenabis Global.

What is the business model of Zenabis Global

Zenabis Global Inc. is a Canadian company specializing in the production and sale of medical and recreational cannabis. It was founded in 2013 and is headquartered in Vancouver, British Columbia. The company operates in three main areas: the medical cannabis market, the recreational cannabis market, and the international market. In the medical segment, Zenabis Global focuses on producing medical cannabis for patients in Canada, including various strains of dried flowers, oils, and capsules available in licensed pharmacies. The company has a production capacity of over 113,000 kg per year. In the recreational market, Zenabis Global produces a wide range of cannabis products, including dried flowers, oils, capsules, and others, distributed through licensed retail stores in Canada. The company also seeks to expand its presence in Europe and Latin America and has formed partnerships in Germany to accelerate market access in Europe. Zenabis Global operates several production facilities in Canada and is licensed and subject to regular inspections by the authorities. The company plans to further increase its production capacity in the coming years and focuses on developing new cannabis products and improving existing product lines to become a global market leader in the industry.

What is the Zenabis Global dividend?

Zenabis Global pays a dividend of 0 CAD distributed over payouts per year.

How often does Zenabis Global pay dividends?

The dividend cannot currently be calculated for Zenabis Global or the company does not pay out a dividend.

What is the Zenabis Global ISIN?

The ISIN of Zenabis Global is CA98936N1024.

What is the Zenabis Global WKN?

The WKN of Zenabis Global is A2PBNN.

What is the Zenabis Global ticker?

The ticker of Zenabis Global is ZENA.TO.

How much dividend does Zenabis Global pay?

Over the past 12 months, Zenabis Global paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zenabis Global is expected to pay a dividend of 0 CAD.

What is the dividend yield of Zenabis Global?

The current dividend yield of Zenabis Global is .

When does Zenabis Global pay dividends?

Zenabis Global pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Zenabis Global?

Zenabis Global paid dividends every year for the past 0 years.

What is the dividend of Zenabis Global?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Zenabis Global located?

Zenabis Global is assigned to the 'Health' sector.

Wann musste ich die Aktien von Zenabis Global kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zenabis Global from 6/30/2025 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 6/30/2025.

When did Zenabis Global pay the last dividend?

The last dividend was paid out on 6/30/2025.

What was the dividend of Zenabis Global in the year 2024?

In the year 2024, Zenabis Global distributed 0 CAD as dividends.

In which currency does Zenabis Global pay out the dividend?

The dividends of Zenabis Global are distributed in CAD.

All fundamentals about Zenabis Global

Our stock analysis for Zenabis Global Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zenabis Global Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.